Adlai Nortye Ltd. ( ANL) - Key Metrics
ANL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.46 | -$0.17 | -$0.48 | -$0.48 |
| 2026Q1 | $0.46 | -$0.17 | -$0.48 | -$0.48 |
| 2025Q4 | $0.23 | -$0.81 | -$3.14 | -$3.15 |
| 2025Q3 | $0.23 | -$0.81 | -$0.86 | -$0.87 |
| 2025Q2 | $0 | $0 | $0 | $0 |
ANL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -17.14 |
| 2026Q1 | 0% | -10.32 |
| 2025Q4 | 0% | -0.44 |
| 2025Q3 | 0% | -0.56 |
| 2025Q2 | 0% | 0 |
ANL
Price: $10.88
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 798.3 million